163 related articles for article (PubMed ID: 17570036)
1. Expression of VEGF and its receptor genes in intracranial schwannomas.
Uesaka T; Shono T; Suzuki SO; Nakamizo A; Niiro H; Mizoguchi M; Iwaki T; Sasaki T
J Neurooncol; 2007 Jul; 83(3):259-66. PubMed ID: 17570036
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors.
Tamura R; Sato M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Murase M; Yoshida K; Toda M
Exp Mol Pathol; 2020 Jun; 114():104408. PubMed ID: 32088190
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF and its receptors in different brain tumors.
Huang H; Held-Feindt J; Buhl R; Mehdorn HM; Mentlein R
Neurol Res; 2005 Jun; 27(4):371-7. PubMed ID: 15949234
[TBL] [Abstract][Full Text] [Related]
4. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor-b in human astrocytoma.
Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.
Xiang F; Tanaka J; Takahashi J; Fukuda T
Brain Tumor Pathol; 2001; 18(2):67-71. PubMed ID: 11908876
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
9. Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients.
Bernatz S; Monden D; Gessler F; Radic T; Hattingen E; Senft C; Seifert V; Ronellenfitsch MW; Plate KH; Harter PN; Baumgarten P
J Mol Histol; 2021 Apr; 52(2):233-243. PubMed ID: 33528717
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
11. The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Linardou H; Kalogeras KT; Kronenwett R; Kouvatseas G; Wirtz RM; Zagouri F; Gogas H; Christodoulou C; Koutras AK; Samantas E; Pectasides D; Bafaloukos D; Fountzilas G
Breast Cancer Res; 2012 Nov; 14(6):R145. PubMed ID: 23146280
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
13. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.
Zygalaki E; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Aug; 53(8):1433-9. PubMed ID: 17599955
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
17. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors.
Khalid H; Yasunaga A; Kishikawa M; Shibata S
Cancer; 1995 May; 75(10):2571-8. PubMed ID: 7736403
[TBL] [Abstract][Full Text] [Related]
20. High mobility group I-C protein in astrocytoma and glioblastoma.
Akai T; Ueda Y; Sasagawa Y; Hamada T; Date T; Katsuda S; Iizuka H; Okada Y; Chada K
Pathol Res Pract; 2004; 200(9):619-24. PubMed ID: 15497774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
